Innovation for Sight
There will be a major change on Glaucoma Treatment soon..
Innovation for Sight
There will be a major change on Glaucoma Treatment soon..
There will be a major change on Glaucoma Treatment soon..
There will be a major change on Glaucoma Treatment soon..
GlaucoT is a smart wearable device designed for gamma rhythm entrainment in order to reduce neuroinflammation.
Mechanical damages on optical nerve are reduced by applying vacuum around the eye globe.
Ocular blood flow is increased with flickering light treatment.
GlaucoT - A new neuroprotective glaucoma treatment device!
'How neuroprotection works by flickering light on Alzheimer's disease?' by MIT.
Alzheimer's disease and Glaucoma has same pathophysiology!
Patient will use GlaucoT at home, with pleasure by their prefered time and will get rid of glaucoma. You could get pleasure of drinking coffee when you are wearing GlaucoT and treat your glaucoma!
We will protect the brain and visual cortex from damaging effect of glaucoma by 40Hz flicker light not with drugs. 40 Hz light is at actually the rhythm of our body and maximum frequency which human eye can see.
This is simple medical consumer electronic device. You don't need to have any surgery or operation to use it so its a non-invasive treatment.
GlaucoT received a 210.00 Euro grant from Germany for the Medical Forge Accelerator program. The Medical Forge Leipzig supports startups and innovative SMEs to bring their medical products faster to the German healthcare market. The customized 12 months program focuses on regulatory requirements for medical devices in the EU https://medicalforge.de/
GlaucoT olarak Almanya'dan 210.000 Euro Hibe kazandık. Medical Forge Leipzig tarafından sağlanan bu hibe ile Almanya’da Glaucot ürünün sağlık sistemine girişini ve klinik çalışmalarını başlatacağız. Nisan ayinda başlayacak ve bir yıl sürecek program için çok heyecanlı ve mutluyuz.
It is our pleasure to announce that our start-up “GlaucoT” has been selected among 16 companies to present at the Start-Up Stadium event from hundreds of startups and entrepreneurs from around the world. We will have the opportunity to introduce Glaucot and our innovation “Wearable Glaucoma Treatment Device” to key members of the investment community, venture philanthropy groups, strategic partners, and non-dilutive capital.
GlaucoT won first place out of 471 projects participating in TET R&D Project Brokerage Event organized by TET - Electrical and Electronics Exporters Association
https://www.tetprojepazari.org/tr/Default.aspx
Göz Tansiyonu (glokom) Tedavisi için geliştirdiğimiz GlaucoT projemiz TET Tarafından düzenlenen 9. Proje Pazarın etkinliğinde 471 proje arasından birinci seçildi. Tüm ekibimize ve bu projede bize destek olan TTGV HIT programına teşekkür ediyoruz. #glokom #glaucoma #ttgv #immib
GlaucoT, World First, noninvasive neuroprotective Glacuoma treatment device on the way, pleasure to get support from TTGV HIT
GlaucoT, dünyanın ilk noninvaziv nöroprotektif Glokom (Göz Tansiyonu) tedavi cihazı yolda, TTGV HIT'den destek almak gurur verici
#TeknolojiÜretenTürkiye #TTGV #glaucoma #glokom #göztansiyonu #innovation #HitProgramı #GlaucoT
We will be at Sands, Hall G - 51322, you could see our working prototype device and we will be more than happy to meet investors for such important project
Our Co-founder Dr. Abdülkadir Oduncu has attended immense training at Acıbadem Incubation center for GlaucoT project commercialization
We would love to meet with our doctors, investors and patients! So feel free to visit us during daily business hours.
Open today | 09:00 am – 05:00 pm |
Copyright © 2021 GlaucoT - All Rights Reserved.